bioAffinity Technologies, Inc. (BIAF)
Nasdaq: BIAF · Services-Commercial Physical & Biological Research · San Antonio, TX · filing with the SEC since 2017
Who runs bioAffinity Technologies, Inc.
Officers and directors as they report to the SEC on Forms 3, 4 and 5, named as filedOfficers reporting now
0
of 2 people with a filing in the last fifteen months
Directors reporting now
2
16 people on the record since 2022
Directorssales are open-market, Sep 30, 2025 to Sep 30, 2026
| Name | Role | First filing | Latest filing | Sales, 12 months |
|---|---|---|---|---|
| Oppenheimer John J. | director | Sep 2025 | Sep 25, 2025 | none |
| Rios Roberto | director | Sep 2025 | Sep 25, 2025 | none |
Earlier names on the record17, newest filing first
Zannes Maria · officer · last filing Jan 2025Girgenti Steven · officer · last filing Jan 2025Edwards James Michael · officer · last filing Jan 2025Reveles Xavier Trinidad · officer · last filing Jan 2025Zannes Timothy P · officer · last filing Jan 2025Anderson Robert A. · director · last filing Jul 2024Diamond Stuart · director · last filing Jul 2024Joyce Roby · director · last filing Jul 2024Knight Peter S · director · last filing Jul 2024Platt Jamie · director · last filing Jul 2024Rubin Gary D · director · last filing Jul 2024Harvey Sandler Revocable Trust · 10% owner · last filing Jul 2024Dougherty Michael Philip · officer · last filing Feb 2024Rebel Vivienne I · officer · last filing Feb 2024Meghji Mohsin Y · director · last filing Jan 2024Joyce Living Trust · other · last filing Jan 2024Perlmutter Nathan M · 10% owner · last filing Mar 2023
A person is listed as reporting now after a filing in the last fifteen months. The record shows when someone last filed; it does not say why they stopped. Each name links to the filings on sec.gov.